Literature DB >> 9632997

Trial design in the era of highly effective antiviral drug combinations for HIV infection.

V DeGruttola1, M Hughes, P Gilbert, A Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9632997

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  ACTG (AIDS Clinical Trials Group) 384: a strategy trial comparing consecutive treatments for HIV-1.

Authors:  L M Smeaton; V DeGruttola; G K Robbins; R W Shafer
Journal:  Control Clin Trials       Date:  2001-04

2.  Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity.

Authors:  J G García Lerma; V Soriano; A Mas; M E Quiñones-Mateu; E J Arts; W Heneine
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Viral suppression in HIV studies: combining times to suppression and rebound.

Authors:  Natalia A Gouskova; Stephen R Cole; Joseph J Eron; Jason P Fine
Journal:  Biometrics       Date:  2014-01-21       Impact factor: 2.571
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.